Medivation, Inc. (MDVN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
81.44+0.02 (+0.02%)
At close: 4:00 PM EDT
People also watch:
BMRNALXNSGENREGNVRTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close81.42
Bid0.00 x
Ask0.00 x
Day's Range81.43 - 81.48
52wk Range26.41 - 81.48
1y Target EstN/A
Market Cap13.52B
P/E Ratio (ttm)-75.34
Beta1.26
Volume4,050,200
Avg Vol (3m)4,284,740
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Market Realist2 days ago

    A Look at the Pfizer-Medivation Deal

    Pfizer-Medivation deal On September 27, 2016, Pfizer (PFE) completed the acquisition of Medivation (MDVN). The stock transaction is valued at $81.50 per Medivation share, resulting in a total enterprise ...

  • Business Wire3 days ago

    Pfizer Completes Acquisition of Medivation

    Pfizer Inc. today announced the successful completion of its acquisition of Medivation, Inc. . As of the tender offer expiration, 115,574,041 shares of Medivation common stock were validly tendered, representing approximately 69.1% of the shares outstanding and have been accepted for payment under the terms of the tender offer for $81.50 per share in cash, without interest, subject to any required ...

  • Marketwired3 days ago

    Medivation Highlights New Data From Differentiated Oncology Portfolio at ESMO 2016

    Medivation, Inc. today announced that new data from Company-sponsored and investigator-initiated clinical trials will be presented at the European Society for Medical Oncology 2016 Congress, being held ...